SG11201810029PA - Immunochromatography Analysis Device for Detecting Zika Virus - Google Patents

Immunochromatography Analysis Device for Detecting Zika Virus

Info

Publication number
SG11201810029PA
SG11201810029PA SG11201810029PA SG11201810029PA SG11201810029PA SG 11201810029P A SG11201810029P A SG 11201810029PA SG 11201810029P A SG11201810029P A SG 11201810029PA SG 11201810029P A SG11201810029P A SG 11201810029PA SG 11201810029P A SG11201810029P A SG 11201810029PA
Authority
SG
Singapore
Prior art keywords
zika virus
analysis device
immunochromatography analysis
immunochromatography
virus
Prior art date
Application number
SG11201810029PA
Inventor
Keita Suzuki
Hisahiko Iwamoto
Original Assignee
Tanaka Precious Metal Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanaka Precious Metal Ind filed Critical Tanaka Precious Metal Ind
Publication of SG11201810029PA publication Critical patent/SG11201810029PA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to an immunochromatography analysis device which enables simple and rapid diagnosis of Zika virus infection, and an object thereof is to provide an immunochromatography analysis device which can reduce a cross-reaction with a virus 5 belonging to Flaviviridae other than Zika virus and which can specifically detect Zika virus. The invention relates to an immunochromatography analysis device for detecting Zika virus including a sample addition part, a labeling substance retaining part, a chromatography medium part having a detection part and an absorption part, wherein the labeling substance retaining part and the detection part each contain an antibody recognizing Zika virus 10 nonstructural protein NS1 of SEQ ID NO: 1.
SG11201810029PA 2016-05-17 2017-05-17 Immunochromatography Analysis Device for Detecting Zika Virus SG11201810029PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016098845A JP6452644B2 (en) 2016-05-17 2016-05-17 Immunochromatographic analyzer for zika virus detection
PCT/JP2017/018540 WO2017200008A1 (en) 2016-05-17 2017-05-17 Immunochromatographic analysis device for detecting zika virus

Publications (1)

Publication Number Publication Date
SG11201810029PA true SG11201810029PA (en) 2018-12-28

Family

ID=60325903

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201810029PA SG11201810029PA (en) 2016-05-17 2017-05-17 Immunochromatography Analysis Device for Detecting Zika Virus

Country Status (7)

Country Link
US (1) US20190162727A1 (en)
EP (1) EP3460475A1 (en)
JP (1) JP6452644B2 (en)
KR (1) KR20180128971A (en)
PH (1) PH12018502389A1 (en)
SG (1) SG11201810029PA (en)
WO (1) WO2017200008A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019039557A1 (en) * 2017-08-24 2019-02-28 富士レビオ株式会社 Method and kit for detecting zika virus
KR102015371B1 (en) * 2017-12-26 2019-08-28 주식회사 수젠텍 Composition for diagnosis of Zika virus and method of diagnosing Zika virus using the same
US11560421B2 (en) 2018-02-09 2023-01-24 Osaka University Broad-spectrum monoclonal antibodies against chikungunya virus E1 structural protein
JP6906207B2 (en) * 2018-02-09 2021-07-21 国立大学法人大阪大学 Immunochromatographic analyzer for chikungunya virus detection
JP2019152666A (en) * 2018-03-02 2019-09-12 富士レビオ株式会社 Method and kit for detecting zika virus
JP7055715B2 (en) * 2018-07-20 2022-04-18 富士レビオ株式会社 Methods and kits for detecting Zika virus antigens and anti-Zika virus antibodies
AU2019310347A1 (en) * 2018-07-23 2021-03-04 The University Of Adelaide Zika virus vaccine
CN112585468A (en) * 2018-09-18 2021-03-30 美国西门子医学诊断股份有限公司 Methods and reagents for Zika virus immunoassay
JP2022505934A (en) * 2018-10-24 2022-01-14 オラシュアテクノロジーズ， インコーポレイテッド Lateral flow assay for differential isotype detection
KR102218517B1 (en) * 2019-01-23 2021-02-19 충북대학교 산학협력단 Method of Detecting Zika Virus Using Monoclonal Antibody Pair
US20220137042A1 (en) * 2020-11-04 2022-05-05 Signature Science, Llc Lateral Flow Assay Device And Sampling Methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI294036B (en) * 2005-02-24 2008-03-01 Tzu Chi Buddhist General Hospital A method for screening compounds against flaviviruses infection by using persistent virus-infected cell systems
JP5792859B1 (en) * 2014-04-04 2015-10-14 田中貴金属工業株式会社 Immunochromatographic analysis method

Also Published As

Publication number Publication date
JP2017207335A (en) 2017-11-24
JP6452644B2 (en) 2019-01-16
KR20180128971A (en) 2018-12-04
US20190162727A1 (en) 2019-05-30
EP3460475A1 (en) 2019-03-27
PH12018502389A1 (en) 2019-07-15
WO2017200008A1 (en) 2017-11-23

Similar Documents

Publication Publication Date Title
SG11201810029PA (en) Immunochromatography Analysis Device for Detecting Zika Virus
CO2018009434A2 (en) Dengue anti-virus ns1 protein monoclonal antibodies
MX2020009021A (en) Assays for detecting the presence or amount of an anti-drug antibody.
MX2021000675A (en) Aav vector and assay for anti-aav (adeno-associated virus) neutralizing antibodies.
MX2015012824A (en) Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection.
BR112017002209A2 (en) method and kit for detecting a dengue virus infection
MX2019001767A (en) Hcv core lipid binding domain monoclonal antibodies.
BR112016009460A8 (en) method to detect the presence of neutralizing antibodies, and, kit
ZA202002415B (en) Detection of symmetrical dimethylarginine
BR112015007606A2 (en) methods and reagents for detecting, quantifying and serotyping dengue virus
WO2013165972A3 (en) Anti-hepatitis b virus antibodies and use thereof
BR112018010764A2 (en) method for detecting bacterial activity in a biological sample and corresponding detection unit
BR112017011545A2 (en) indirect homogeneous mobility shift assay for detection of biological products in patient samples
BR112016015537A2 (en) methods and kits for detecting the presence of the polynucleotide sequence of e.g. histolytica in sample
WO2014143864A3 (en) Methods of detecting influenza virus
EA201400571A1 (en) SPECIFIC TO TRANSRESVEROTROL ANTIBODIES AND THEIR APPLICATION
WO2016069762A3 (en) Subject anti-hcv antibody detection assays employing ns3 capture peptides
HRP20221059T1 (en) Method and agents for detecting luciferase activity
WO2014126487A3 (en) Diagnosis and detection of dengue virus infection using chicken egg antibodies
BR112017020539B8 (en) Reagent for immunoassay comprising a polypeptide, methods of detecting antibodies and/or antigens to hepatitis c virus in a biological sample, of selecting biological samples from a supply of human biological samples, as well as isolated polypeptide and kit for immunodiagnostic testing
MX365962B (en) Method for detecting an infection by the hepatitis c virus.
MY151190A (en) Method of detecting pork in processed food and detection kit therefor
WO2015077541A3 (en) Mycobacterium biomarkers and methods
MY186716A (en) Methods of detecting arthropod-borne virus by recombinant baculoviruses
DE502006005985D1 (en) TEST SYSTEM FOR THE DETECTION OF SALMONELLES